Robert Paccasassi - Feb 13, 2024 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
VP, QA and Reg Compliance
Signature
/s/ Robert Paccasassi
Stock symbol
BRTX
Transactions as of
Feb 13, 2024
Transactions value $
$0
Form type
4
Date filed
2/15/2024, 04:19 PM
Previous filing
Feb 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Award $0 +219K $0.00 219K Feb 13, 2024 Common Stock 219K $1.45 Direct F3
holding BRTX Stock Option 8.28K Feb 13, 2024 Common Stock 8.28K $5.08 Direct F1
holding BRTX Stock Option 89K Feb 13, 2024 Common Stock 89K $2.91 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is currently exercisable.
F2 The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.
F3 The option vests and becomes exercisable to the extent of 109,649 shares on February 13, 2024 with the remaining 109,649 shares vesting in eight nearly-equal quarterly installments beginning on February 13, 2025 and continuing every three months thereafter until fully vested.